Notice of Meeting, 58267-58268 [2018-25116]

Download as PDF 58267 Federal Register / Vol. 83, No. 223 / Monday, November 19, 2018 / Notices Name of Committee: National Human Genome Research Institute Special Emphasis Panel; H3Africa Biorepository. Date: December 14, 2018. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: NHGRI, Greider Conference Room 3321, 6700B Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD 20852, (301) 402–0838, pozzattr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: November 13, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–25108 Filed 11–16–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and, (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Proposed Project: 2019 National Survey on Drug Use and Health (OMB No. 0930–0110)—Extension Agency Information Collection Activities: Proposed Collection; Comment Request The data are used to determine the prevalence of use of tobacco products, alcohol, illicit substances, and illicit use of prescription drugs. The results are used by SAMHSA, the Office of National Drug Control Policy (ONDCP), federal government agencies, and other organizations and researchers to establish policy, to direct program activities, and to better allocate resources. This is an extension to the 2019 National Survey on Drug Use and Health (NSDUH). There are no substantive changes to the questionnaire or changes in burden. The 2019 NSDUH will continue to include questions on medication-assisted treatment (MAT) and kratom. As with all NSDUH surveys conducted since 1999, including those prior to 2002 when the NSDUH was referred to as the National Household Survey on Drug Abuse, the sample size of the survey for 2019 will be sufficient to permit prevalence estimates for each of the 50 states and the District of Columbia. The total annual burden estimate is shown below in Table 1. The National Survey on Drug Use and Health (NSDUH) is a survey of the U.S. civilian, non-institutionalized population aged 12 years old or older. In compliance with section 3506(c)(2)(A) of the Paperwork TABLE 1—ANNUALIZED ESTIMATED BURDEN FOR 2019 NSDUH Number of respondents Instrument Total number of responses Hours per response Total burden hours Household Screening ........................................................... Interview ............................................................................... Screening Verification .......................................................... Interview Verification ............................................................ 137,231 67,507 4,116 10,126 1 1 1 1 137,231 67,507 4,116 10,126 0.083 1.000 0.067 0.067 11,390 67,507 276 678 Total .............................................................................. 137,231 ........................ 218,980 ........................ 79,851 Send comments to Summer King, SAMHSA Reports Clearance Officer, Room 15E57B, 5600 Fishers Lane, Rockville, MD 20857 or email a copy to summer.king@samhsa.hhs.gov. Written comments should be received by January 18, 2019. Summer King, Statistician. khammond on DSK30JT082PROD with NOTICES Responses per respondent [FR Doc. 2018–25142 Filed 11–16–18; 8:45 am] BILLING CODE 4162–20–P VerDate Sep<11>2014 17:20 Nov 16, 2018 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention’s (CSAP) Drug Testing Advisory Board (DTAB) will convene via in person and web conference on December 4, 2018, from 9:00 a.m. EST to 3:30 p.m. EST and December 5, 2018, from 9:00 a.m. EST to 4:00 p.m. PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 The Board will meet in open-session in-person on December 4, 2018, from 9:00 a.m. EST to 3:30 p.m. EST to discuss the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs (urine specimens) with updates from the Department of Transportation, Nuclear Regulatory Commission, and the Department of Defense. There will be additional presentations from the Division of Workplace Programs’ staff on urine, oral fluid, hair Mandatory Guidelines and future direction, updates on electronic chain of custody and standard variables, and emerging issues surrounding marijuana legalization. The board will meet in closed-session in-person on E:\FR\FM\19NON1.SGM 19NON1 58268 Federal Register / Vol. 83, No. 223 / Monday, November 19, 2018 / Notices December 5, 2018, from 9:00 a.m. EST to 4:00 p.m. EST to discuss confidential issues surrounding the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs (urine specimens, oral fluid, hair), invalids, studies from Johns Hopkins Behavioral Pharmacology Research Unit, impact of cannabis laws on drug testing and future direction, potential recommendations to the Assistant Secretary for Mental Health and Substance Use regarding additional drugs that may be tested for in the future, and lastly, program financials. Therefore, the December 5, 2018, meeting is closed to the public, as determined by the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d). Meeting registration information can be completed at https:// snacregister.samhsa.gov/ MeetingList.aspx. Web conference and call information will be sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, https://www.samhsa.gov/ about-us/advisory-councils/meetings or by contacting the Designated Federal Officer, CAPT Sean J. Belouin, USPHS. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: December 4, 2018, from 9:00 a.m. to 3:30 p.m. EST: Open; December 5, 2018, from 9:00 a.m. to 4:00 p.m. EST: Closed. Place: Hilton Washington DC/Rockville Hotel & Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. Contact: CAPT Sean J. Belouin, USPHS, Senior Pharmacology and Regulatory Policy Advisor, Division of Workplace Programs, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 20857, Telephone: (240) 276–2600, Email: sean.belouin@samhsa.hhs.gov. Charles LoDico, Chemist. [FR Doc. 2018–25116 Filed 11–16–18; 8:45 am] khammond on DSK30JT082PROD with NOTICES BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2018–0791] Collection of Information Under Review by Office of Management and Budget; OMB Control Number: 1625– 0018 Coast Guard, DHS. Thirty-day notice requesting comments. AGENCY: ACTION: In compliance with the Paperwork Reduction Act of 1995 the U.S. Coast Guard is forwarding an Information Collection Request (ICR), abstracted below, to the Office of Management and Budget (OMB), Office of Information and Regulatory Affairs (OIRA), requesting approval for reinstatement, without change, of the following collection of information: 1625–0018, Official Logbook. Our ICR describe the information we seek to collect from the public. Review and comments by OIRA ensure we only impose paperwork burdens commensurate with our performance of duties. DATES: Comments must reach the Coast Guard and OIRA on or before December 19, 2018. ADDRESSES: You may submit comments identified by Coast Guard docket number [USCG–2018–0791] to the Coast Guard using the Federal eRulemaking Portal at https://www.regulations.gov. Alternatively, you may submit comments to OIRA using one of the following means: (1) Email: dhsdeskofficer@ omb.eop.gov. (2) Mail: OIRA, 725 17th Street NW, Washington, DC 20503, attention Desk Officer for the Coast Guard. A copy of the ICR is available through the docket on the internet at https:// www.regulations.gov. Additionally, copies are available from: Commandant (CG–612), Attn: Paperwork Reduction Act Manager, U.S. Coast Guard, 2703 Martin Luther King Jr Ave SE, Stop 7710, Washington, DC 20593–7710. FOR FURTHER INFORMATION CONTACT: Mr. Anthony Smith, Office of Information Management, telephone 202–475–3532, or fax 202–372–8405, for questions on these documents. SUPPLEMENTARY INFORMATION: SUMMARY: Public Participation and Request for Comments This Notice relies on the authority of the Paperwork Reduction Act of 1995; 44 U.S.C. Chapter 35, as amended. An VerDate Sep<11>2014 17:20 Nov 16, 2018 Jkt 247001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 ICR is an application to OIRA seeking the approval, extension, or renewal of a Coast Guard collection of information (Collection). The ICR contains information describing the Collection’s purpose, the Collection’s likely burden on the affected public, an explanation of the necessity of the Collection, and other important information describing the Collection. There is one ICR for each Collection. The Coast Guard invites comments on whether this ICR should be granted based on the Collection being necessary for the proper performance of Departmental functions. In particular, the Coast Guard would appreciate comments addressing: (1) The practical utility of the Collection; (2) the accuracy of the estimated burden of the Collection; (3) ways to enhance the quality, utility, and clarity of information subject to the Collection; and (4) ways to minimize the burden of the Collection on respondents, including the use of automated collection techniques or other forms of information technology. These comments will help OIRA determine whether to approve the ICR referred to in this Notice. We encourage you to respond to this request by submitting comments and related materials. Comments to Coast Guard or OIRA must contain the OMB Control Number of the ICR. They must also contain the docket number of this request, [USCG–2018–0791], and must be received by December 19, 2018. Submitting Comments We encourage you to submit comments through the Federal eRulemaking Portal at https:// www.regulations.gov. If your material cannot be submitted using https:// www.regulations.gov, contact the person in the FOR FURTHER INFORMATION CONTACT section of this document for alternate instructions. Documents mentioned in this notice, and all public comments, are in our online docket at https://www.regulations.gov and can be viewed by following that website’s instructions. Additionally, if you go to the online docket and sign up for email alerts, you will be notified when comments are posted. We accept anonymous comments. All comments received will be posted without change to https:// www.regulations.gov and will include any personal information you have provided. For more about privacy and the docket, you may review a Privacy Act notice regarding the Federal Docket Management System in the March 24, 2005, issue of the Federal Register (70 FR 15086). E:\FR\FM\19NON1.SGM 19NON1

Agencies

[Federal Register Volume 83, Number 223 (Monday, November 19, 2018)]
[Notices]
[Pages 58267-58268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25116]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via in person and web conference on December 
4, 2018, from 9:00 a.m. EST to 3:30 p.m. EST and December 5, 2018, from 
9:00 a.m. EST to 4:00 p.m.
    The Board will meet in open-session in-person on December 4, 2018, 
from 9:00 a.m. EST to 3:30 p.m. EST to discuss the proposed Mandatory 
Guidelines for Federal Workplace Drug Testing Programs (urine 
specimens) with updates from the Department of Transportation, Nuclear 
Regulatory Commission, and the Department of Defense. There will be 
additional presentations from the Division of Workplace Programs' staff 
on urine, oral fluid, hair Mandatory Guidelines and future direction, 
updates on electronic chain of custody and standard variables, and 
emerging issues surrounding marijuana legalization. The board will meet 
in closed-session in-person on

[[Page 58268]]

December 5, 2018, from 9:00 a.m. EST to 4:00 p.m. EST to discuss 
confidential issues surrounding the proposed Mandatory Guidelines for 
Federal Workplace Drug Testing Programs (urine specimens, oral fluid, 
hair), invalids, studies from Johns Hopkins Behavioral Pharmacology 
Research Unit, impact of cannabis laws on drug testing and future 
direction, potential recommendations to the Assistant Secretary for 
Mental Health and Substance Use regarding additional drugs that may be 
tested for in the future, and lastly, program financials. Therefore, 
the December 5, 2018, meeting is closed to the public, as determined by 
the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in 
accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, 
Section 10(d).
    Meeting registration information can be completed at https://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, CAPT Sean J. Belouin, USPHS.

    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: December 4, 2018, from 9:00 a.m. to 3:30 p.m. 
EST: Open; December 5, 2018, from 9:00 a.m. to 4:00 p.m. EST: 
Closed.
    Place: Hilton Washington DC/Rockville Hotel & Executive Meeting 
Center, 1750 Rockville Pike, Rockville, MD 20852.
    Contact: CAPT Sean J. Belouin, USPHS, Senior Pharmacology and 
Regulatory Policy Advisor, Division of Workplace Programs, 5600 
Fishers Lane, Room 16N06D, Rockville, Maryland 20857, Telephone: 
(240) 276-2600, Email: [email protected].

Charles LoDico,
Chemist.
[FR Doc. 2018-25116 Filed 11-16-18; 8:45 am]
 BILLING CODE 4162-20-P